The role of the atria in congenital heart disease

Cardiology Clinics

Volumn 20, Issue 3, 2002, Pages 351-366

  Meijboom, Folkert ^a   Roos Hesselink, Jolien ^a   Sievert, Horst ^b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b CARDIOANGIOLOGISCHES CENTRUM BETHANIEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANEURYSM; CONGENITAL HEART DISEASE; HEART ATRIUM; HEART ATRIUM FUNCTION; HEART ATRIUM SEPTUM DEFECT; HEART CATHETERIZATION; HEART MUSCLE COMPLIANCE; HEART SURGERY; HUMAN; PRESSURE VOLUME CURVE; PRIORITY JOURNAL; REVIEW; SUPRAVENTRICULAR TACHYCARDIA;

EID: 0036696145     PISSN: 07338651     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0733-8651(02)00006-1     Document Type: Article

References (104)

1. Braunwald E, Frahm CJ. Studies on Starling's law of the heart. Circulation 1961;23:633-42.
2. Hoit BD. Left atrial function in health and disease. Eur Heart J 2000;2(Suppl K):9-16.
3. Linderer T, Chatterjee K, Parmley WW, et al. Influence of atrial systole on the Frank-Starling relation and the end-diastolic pressure-diameter relation of the left ventricle. Circulation 1983;67:1045-53.
4. Stefanidis C, Dernellis J, Toutouzas P. A clinical appraisal of left atrial function. Eur Heart J 2000;22:22-36.
5. Therrien J, Sam SC, Harris L, et al. Impact of pulmonary valve replacement on arrhythmia propensity late after repair of tetralogy of Fallot. Circulation 2001;103:2489-94.
6. Trusler GA, Bull RC, Hoeksema T, et al. The effect on cardiac output of a reduction in atrial volume. J Thorac Cardiovasc Surg 1963;49:109-16.
7. Grant C, Bunell IL, Greene DG. The reservoir function of the left atrium during ventricular systole. Am J Cardiol 1964;27:36-43.
8. Sherriff DD, Luo Z. Capacitive function of the heart: influence of acute changes in volume on mean right atrial pressure. Am J Physiol 1997;272: H553-8.
9. Hintze TH, McIntyre JJ, Patel MB, et al. Atrial wall function and plasma atriopeptin during volume expansion in conscious dogs. Am J Physiol 1989;256:H713-9.
10. Hamilton DR, Dani RS, Semlacher RA, et al. Right atrial and right ventricular transmural pressure in dogs and humans. Effects of the pericardium. Circulation 1994;90(5):2492-500.
11. Hartman H. The jugular venous tracing. Am Heart J 1960;59:698-704.
12. Hitch DC, Nolan SP. Descriptive analysis of instantaneous left atrial volume-with specific reference to left atrial function. J Surg Res 1981;30:110-20.
13. Little WC, Cheng CP. Left atrial role in left ventricular filling at rest during exercise and during development of heart failure. Eur Heart J 2000;2(Suppl K):17-25.
14. Mitchell JH, Gilmore JP, Sarnoff SJ. The transport function of the atrium. Am J Cardiol 1962;9:237-47.
15. Rahimtoola SH, Ehsani A, Sinno MZ, et al. Left atrial transport function in myocardial infarction. Importance of its booster pump function. Am J Med 1975;59:686-94.
16. Peniston CM, Spence PA, Mihic N, et al. The effects of cardioplegic arrest on right atrial function. Ann Thorac Surg 1986;41(5):473-7.
17. Smiseth OA, Thompson CR, Lohavanichbutr K, et al. The pulmonary venous systolic flow pulse - its origin and relation to left atrial pressure. J Am Coll Cardiol 1999;34:802-9.
18. Lambertz H, Krebs W, Sechtem U, et al. Analysis of right atrium function in patients with chronic pressure overload of the right ventricle. Z Kardiol 1985;74:402-8.
19. Gibbs JL, Wilson N, Witsenburg M, et al. Diastolic forward flow in the pulmonary artery detected by Doppler echocardiography. J Am Coll Cardiol 1985;6:1322-8.
20. Roos-Hesselink J, Perlroth MG, McGhie J, et al. Atrial arrhythmias in adults after repair of tetralogy of Fallot. Circulation 1995;92:2214-9.
21. Therrien J, Siu SC, McLaughlin PR, et al. Pulmonary valve replacement in adults late after repair of tetralogy of Fallot: Are we operating too late? J Am Coll Cardiol 2000;36:1670-5.
22. Leistadt E, Christensen G, Ilebekk A. Effects of atrial fibrillation on left and right atrial dimensions, pressures and compliances. Am J Physiol 1993;264(4pt2):1093-7.
23. Alam M, Thorstrand C. Left ventricular function in patients with atrial fibrillation before and after cardioversion. Am J Cardiol 1992;69:694-6.
24. Gosselink ATM, Crijns HJGM, Hamer HPM, et al. Changes in left and right atrial size after cardioversion of atrial fibrillation: role of mitral valve disease. J Am Coll Cardiol 1993;22:1666-72.
25. Kannel WB, Abbott RD, Savage DD, et al. Epidemiologic features of chronic atrial fibrillation: the Framingham study. New Engl J Med 1982;306:1018-22.
26. Saul JP, Triedman JK. Radiofrequency ablation of intraatrial reentrant tachycardia after surgery for congenital heart disease. PACE 1997;20:2112-7.
27. Flinn C, Wolff G, Dick M, et al. Cardiac rhythm after the Mustard operation for complete transposition of the great arteries. N Engl J Med 1984;310:1635-8.
28. Foster E, Graham TP Jr, Landzberg MJ, et al. Complications and morbidity in adults with Fontan physiology: a multicentre study (abstr). Circulation 1999;100(Suppl 1):1669.
29. Garson A, Bink-Boelkens M, Hesslein P, et al. Atrial flutter in the young: a collaborative study of 380 cases. J Am Coll Cardiol 1985;6:871-8.
30. Ghai A, Harris L, Harrison DA, et al. Outcomes of late atrial tachyarrhythmias in adults after the Fontan operation. J Am Coll Cardiol 2001;37:585-92.
31. Meijboom FJ, Hess J, Szatmari A, et al. Long-term follow-up (9-20 years) after surgical closure of atrial septal defect at young age. Am J Cardiol 1993;72:1431-3.
32. Meijboom F, Szatmari A, Deckers JW, et al. Longterm follow-up (10 to 17 years) after Mustard repair for transposition of the great arteries. J Thorac Cardiovasc Surg 1996;111:1158-68.
33. Meijboom F, Szatmari A, Deckers JW, et al. Cardiac status and health-related quality of life in the long term after surgical repair of tetralogy of Fallot in infancy and childhood. J Thorac Cardiovasc Surg 1995;110:883-91.
34. Murphy JG, Gersh BJ, Mair DD, et al. Long-term outcome in patients undergoing surgical repair of tetralogy of Fallot. N Engl J Med 1993;329:593-9.
35. Yellin EL, Sonnenblick EH, Frater RWM. Left ventricular filling. In: Baan J, Arntzenius AC, Yellin EL, editors. Cardiac Haemodynamics. Martinus Nijhoff publishers. 1980. p. 148-152.
36. Clark DM, Plumb VJ, Epstein AE, et al. Hemodynamic effects of an irregular sequence of ventricular cycle lengths during atrial fibrillation. J Am Coll Cardiol 1997;30:1039-45.
37. Daoud R, Weiss M, Bahu BP, et al. Effect of an irregular ventricular rhythm on cardiac output. Am J Cardiol 1996;78:1433-6.
38. Killip T, Baer RA. Hemodynamic effects after reversion from atrial fibrillation to sinus rhythm by precordial shock. J Clin Invest 1966;45:658-71.
39. Silka M, Hardy B, Menashe V, et al. A population-based prospective evaluation of risk of sudden cardiac death after operation for common congenital heart defects. J Am Coil Cardiol 1998;32:245-51.
40. Alboni P, Scarfo S, Fuca G, et al. Atrial and ventricular pressures in atrial flutter. PACE 1999;22:600-4.
41. Gillette PC, Wampler DG, Shannon C, et al. Use of cardiac pacing after the Mustard operation for transposition of the great arteries. J Am Coll Cardiol 1986;7:138-41.
42. Silka MJ, Manwill JR, Kron J, et al. Bradycardia-mediated tachyarrhythmias in congenital heart disease and responses to chronic pacing at physiologic rates. Am J Cardiol 1990;65:488-93.
43. Samet P. Hemodynamic sequelae of cardiac arrhythmias. Circulation 1973;157:399-405.
44. Samet P, Castillo C, Bernstein WH. Hemodynamic sequelae of atrial, ventricular and sequential atrioventricular pacing in cardiac patients. Am Heart J 1966;72:725-9.
45. Cazeau S, Leclerc C, Lavergne T, et al. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med 2001;344:873-80.
46. Triedman JK, Alexander ME, Berul CI, et al. Electroanatomic mapping of entrained and exit zones in patients with repaired congenital heart disease and intra-atrial reentrant tachycardia. Circulation 2001;103:2060-5.
47. Zrenner B, Ndrepepa G, Schneider MAE, et al. Mapping and ablation of atrial arrhythmias after surgical correction of congenital heart disease guided by a 64-electrode basket catheter. Am J Cardiol 2001;88:573-8.
48. Tang AS, Morton BC, Green MS, et al. Improvement of ventricular function after atrioventricular junction ablation in a patient with atrial flutter after Mustard's operation. Can J Cardiol 1996;12:523-5.
49. Lau CP, Leung WH, Wong WH, et al. Haemodynamics of induced atrial fibrillation: a comparative assessment with sinus rhythm, atrial and ventricular pacing. Eur Heart J 1990;11:219-24.
50. Cox JL, Boineau JP, Schuessler RB, et al. Five-years experience with the maze procedure for atrial fibrillation. Ann Thorac Surg 1993;56:814-24.
51. Jordaens L, Missault L, Germonpre, et al. Delayed restoration of atrial function after conversion of atrial flutter by pacing or electrical cardioversion. Am J Cardiol 1993;71:63-7.
52. Manning WJ, Silverman DI, Katz SE, et al. Impaired left atrial mechanical function after cardioversion: relation to the duration of atrial fibrillation. J Am Coll Cardiol 1994;23:1535-40.
53. Feinberg MS, Waggoner AD, Kater KM, et al. Restoration of atrial function after the maze procedure for patients with atrial fibrillation: assessment by Doppler echocardiography. Circulation 1994;90:285-92.
54. Yashima N, Kawazoe K, Hiramori K. Serial evaluation of atrial function by Doppler echocardiography after the maze procedure for chronic atrial fibrillation. Eur Heart J 1997;18:496-502.
55. Balaji S, Johnson TB, Sade RM, et al. Management of atrial flutter after the Fontan procedure. J Am Coll Cardiol 1994;23:1209-15.
56. Mavroudis C, Backer CL, Deal BJ, et al. Total cavopulmonary conversion and maze procedure for patients with failure of the Fontan operation. J Thorac Cardiovasc Surg 2001;122:863-71.
57. Chambers JB, de Belder MA, Moore D. Echocardiography in stroke and transient ischaemic attack. Heart 1997;78(Suppl 1):2-6.
58. Hart RG, Miller VT. Cerebral infarction in young adults: a practical approach. Stroke 1983;14:110-4.
59. Mas JL. Patent foramen ovale, atrial septal aneurysm and ischaemic stroke in young adults. Eur Heart J 1994;15:446-9.
60. Cosyns B, Schulze D, Van Camp G, et al. Relationship Between Patent Foramen Ovale and Unexplained Stroke. A Study by Quantitative Transesophageal Contrast Echocardiography. Circulation 1992;86(Suppl 1):146.
61. Di Tullio M, Sacco RL, Venketasubramanian N, et al. Comparison of diagnostic techniques for the detection of a patent foramen ovale in stroke patients. Stroke 1993;24:1020-4.
62. Hart RG. Cardiogenic embolism to the brain. Lancet 1992;339:589-94.
63. Mas JL, Zuber M. For the French Study Group of patent foramen ovale and atrial septal aneurysm: recurrent cerebrovascular events in patients with patent foramen ovale, atrial septal aneurysm, or both and cryptogenic stroke or transient ischemic attack. Am Heart J 1995;130:1083-8.
64. Welch PJ, Afridi I, Joglar JA, et al. Effect of radiofrequency ablation on atrial mechanical function in patients with atrial flutter. Am J Cardiol 1999;84:420-5.
65. Hanley PC, Tajik AJ, Hynes JK, et al. Diagnosis and Classification of Atrial Septal Aneurysm by Two-Dimensional Echocardiography: Report of 80 Consecutive Cases. J Am Coll Cardiol 1985;6:1370-82.
66. Agmon Y, Khandheria BK, Meissner I, et al. Frequency of atrial septal aneurysms in patients with cerebral ischemic events. Circulation 1999;99:1942-4.
67. Cabanes L, Mas JL, Cohen A, et al. Atrial septal aneurysm and patent foramen ovale as risk factors for cryptogenic stroke in patients less than 55 years of age. A study using transesophageal echocardiography. Stroke 1993;24:1865-73.
68. Hausmann D, Mugge A, Becht I, et al. Diagnosis of patent foramen ovale by transesophageal echocardiography and association with cerebral and peripheral embolic events. Am J Cardiol 1992;70:668-72.
69. Hausmann D, Mügge A, Daniel WG. Identification of Patent Foramen Ovale Permitting Paradoxic Embolism. J Am Coll Cardiol 1995;26:1030-8.
70. Overell JR, Bone I, Lees KR. Interatrial septal abnormalities and stroke: A meta-analysis of case-control studies. Neurology 2000;55:1172-9.
71. Zabalgoitia-Reyes M, Herrera C, Gandhi DK, et al. A possible mechanism for neurologic ischemic events in patients with atrial septal aneurysm. Am J Cardiol 1990;66:761-1174.
72. Balli E, Alfieri A, Del Citerna F. Direct evidence of patent foramen ovale as a route for paradoxical embolism. Br Heart J 1995;74:470.
73. Falk V, Walther T, Krankenberg H, et al. Trapped thrombus in a patent foramen ovale. Thorac Cardiovasc Surg 1997;45:90-2.
74. Mügge A, Daniel WG, Angermann C, et al. Atrial Septal Aneurysm in Adult Patients. A Multicenter Study Using Transthoracic and Transesophageal Echocardiography. Circulation 1995;91:2785-92.
75. Nagelhout DA, Pearson AC, Labovitz AJ. Diagnosis of paradoxic embolism by transesophageal echocardiography. Am Heart J 1991;121:1552-4.
76. Belder de MA, Tourikis L, Leech G, et al. Risk of patent foramen ovale for thromboembolic events in all age groups. Am J Cardiol 1992;69:1316-20.
77. Hagen PT, Scholz DG, Edwards WD. Incidence and Size of Patent Foramen Ovale During the First 10 Decades of Life: An Autopsy Study of 967 Normal Hearts. Mayo Clin Proc 1984;59:17-20.
78. Job FP, Ringelstein EB, Grafen Y, et al. Comparison of Transcranial Contrast Doppler Sonography and Transesophageal Contrast Echocardiography for the Detection of Patent Foramen Ovale in Young Stroke Patients. Am J Cardiol 1994;74:381-4.
79. Lechat P, Mas JL, Lascault G, et al. Prevalence of patent foramen ovale in patients with stroke. N Engl J Med 1988;318:1148-52.
80. Steiner MM, Di Tullio MR, Rundek T, et al. Patent foramen ovale size and embolic brain imaging findings among patients with ischemic stroke. Stroke 1998;29:944-8.
81. Stone DA, Godard J, Coretti MC, et al. Patent foramen ovale: Association between the degree of shunt by contrast transesophageal echocardiography and the risk of future ischemic neurologic events. Am Heart J 1996;131:158-61.
82. Bogousslavsky J, Devuyst G, Nendaz M, et al. Prevention of stroke recurrence with presumed paradoxical embolism. J Neurol 1997;244:71-5.
83. Bogousslavsky J, Garazi S, Jeanrenaud X, et al. Stroke recurrence in patients with patent foramen ovale: the Lausanne Study. Lausanne Stroke with Paradoxical Embolism Study Group. Neurology 1996;46:1301-5.
84. The CASANOVA Study Group. Carotid surgery versus medical therapy in asymptomatic carotid stenosis. Stroke 1991;22:1229-35.
85. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. Endarterectomy for asymptomatic carotid artery stenosis. JAMA 1995; 273:1421-8.
86. Albers GW. Atrial fibrillation and stroke. Three new studies, three remaining questions. Arch Intern Med 1994;154:1443-8.
87. Nendaz M, Sarasin F, Bogousslavsky J. How to Prevent Stroke Recurrence in Patients with Patent Foramen ovale: Anticoagulants, Antiaggregants, Foramen Closure, or Nothing? Eur Neurol 1997;37:199-204.
88. Sacco RL, Ellenberg JH, Mohr JP, et al. Infarcts of undetermined cause: the NINCDS Stroke Data Bank. Ann Neurol 1989;25:382-90.
89. Caes FL, Van Belleghem YV, Missault LH, et al. Surgical treatment of impending paradoxical embolism through patent foramen ovale. Ann Thorac Surg 1995;59:1559-61.
90. Dearani JA, Ugurlu BS, Danielson GK, et al. Surgical patent foramen ovale closure for prevention of paradoxical embolism-related cerebrovascular ischemic events. Circulation 1999;100(Suppl 11):171-5.
91. Devuyst G, Bogousslavsky J, Ruchat P, et al. Prognosis after stroke followed by surgical closure of patent foramen ovale: a prospective follow-up study with brain MRI and simultaneous transesophageal and transcranial Doppler ultrasound. Neurology 1996;47:1162-6.
92. Homma S, Di Tullio MR, Sacco RL, et al. Characteristics of patent foramen ovale associated with cryptogenic stroke. A Biplane Transesophageal Echocardiographic Study. Stroke 1994;47:582-6.
93. Homma S, Di Tullio MR, Sacco RL, et al. Surgical closure of patent foramen ovale in cryptogenic stroke patients. Stroke 1997;28:2376-81.
94. Ruchat P, Bogousslavsky J, Hurni M, et al. Systematic surgical closure of patent foramen ovale in selected patients with cerebrovascular events due to paradoxical embolism. Early results of a preliminary study. Eur J Cardiothorac Surg 1997;11:824-7.
95. Bridges ND, Hellenbrand W, Latson L, et al. Transcatheter closure of patent foramen ovale after presumed paradoxical embolism. Circulation 1992;86:1902-8.
96. Ende DJ, Chopra PS, Rao PS. Transcatheter closure of atrial septal defect or patent foramen ovale with the buttoned device for prevention of recurrence of paradoxic embolism. Am J Cardiol 1996;78:233-6.
97. Hung J, Landzberg MJ, Jenkins KJ, et al. Closure of patent foramen ovale for paradoxical emboli: intermediate-term. J Am Coll Cardiol 2000;35:1311-6.
98. Sievert H, Babic UU, Hausdorf G, et al. Transcatheter closure of atrial septal defect and patent foramen ovale with the ASDOS device (a multi-institutional European trial). Am J Cardiol 1998;82:1405-13.
99. Teupe C, Schneider M, Nacimiento W, et al. Interventional closure of an open foramen ovale in a patient with recurrent cerebral ischemia. Nervenarzt 1995;66:634-7.
100. Walsh KP, Wilmshurst PT, Morrison WL. Transcatheter closure of patent foramen ovale using the Amplatzer septal occluder to prevent recurrence of neurological decompression illness in divers. Heart 1999;81:257-61.
101. Windecker S, Wahl A, Chatterjee T, et al. Percutaneous closure of patent foramen ovale in patients With paradoxical embolism. Long-term risk of recurrent thromboembolic events. Circulation 2000;101:893-8.
102. Sievert H, Krumsdorf U, Trepels T, et al. Catheter closure of atrial septal defects and patent foramen ovale in association with atrial septal aneurysm using different devices. Europ Heart J 2001;22(Suppl):85.
103. Sievert H, Richens T, Hillis WS, et al. Early total world clinical experience with a novel nitinol/ePTFE based double disc atrial septal occlusion device. Europ Heart J 2000;1(Abstr Suppl):432.
104. Sacco RL, Di Tullio MR, Homma S. Treatment of patent foramen ovale and stroke: To close or not to close, that is not yet the question. Eur Neurol 1997;37:205-6.